Role of PET Role of PET-CT in Pulmonary Malignancy

More documents

Recommendations

Info

PPV of FDG-PET = 90% (9595%confidence interval [CI], 69%-9898%)NPV of FDG-PET = 98% (9595% CI,92%-99%). PPV of Bone scan = 35% (95% CI,23%-49%) )and NPV of Bone scan = 96% (95% CI,88%-9999%),Bury et al Eur J Nucl Med.1998;25:1244-12471247
145 patients on a lesion-byby-lesionbasis Sensitivity of FDG-PET = 87.5%Specificity of FDG PET= 97.3%Sensitivity for bone scans = 81.2%Specificity for bone scans = 74.3% Cheon et al J Nucl Med. 2007;40;40:96.
Page 1 and 2:
Role of PET-CT inPulmonary Malignan
Page 3 and 4:
CLINICAL APPLICATION OFPET SCAN ONC
Page 5 and 6:
F-18-FDG PET - IndicationsPrimary T
Page 7:
TRACER FOR PET C-11 acetate N-13amm
Page 10 and 11:
CLINICAL ASPECT OF PET Primary stag
Page 12 and 13:
PET/FDG in Lung Cancer Prognosis Ra
Page 15 and 16: Diagnosis i SPNMeta-analysisanalysi
Page 20 and 21: Diagnosis i SPNROLE of FDG/PETInter
Page 22 and 23: Study in Khon Khan U Benign 50 % Pr
Page 24 and 25: AJR 2006; 187:13611361-13671367Sens
Page 26 and 27: CT 93%/ %/3131% ( sen/spec)PET 69%/
Page 28 and 29: Is there a role for PET in theevalu
Page 37: Staging:NSCLCT staging (CT is more
Page 42 and 43: CT scan The NCCN guideline panel :
Page 44 and 45: N stagingCT PETMeta-analysisanalysi
Page 46 and 47: Mediastinoscopy is the gold standar
Page 56 and 57: Advances in PET technologyhave incr
Page 63: Can PET/CT substitute for bonescint
Page 67: skeletal l metastases t were detect
Page 74: 1 year later
Page 82 and 83: Adrenal gl met Adrenal metastases a
Page 84 and 85: 51 of 175 masses were 1.5 cm orless
Page 86 and 87: Eur J Nucl Med Imaging 2006Jan;33(1
Page 89 and 90: StagingNSCLCImpact of PET/FDG stagi
Page 91 and 92: Thank you
Page 93 and 94: lymphangitis carcinomatosis Less of
show all

Role of PET Role of PET-CT in Pulmonary Malignancy

Create successful ePaper yourself

Delete template?

Save as template?